Find abstracts, slides and webcasts from ESMO Immuno-Oncology Congress 2019.
ESMO Immuno-Oncology Congress 2019
- Start date
- 11 Dec 2019
- End date
- 14 Dec 2019
- Location
- Geneva, Switzerland
The ESMO Immuno-Oncology Congress 2019 is a global meeting taking place in the heart of Europe
From the basics of immunotherapies to the latest research results; from understanding different treatment options to management of toxicities and interpretation of new data, the Congress brings together the European community of immuno-oncology stakeholders. Take this unique opportunity to learn, share your research and build invaluable collaborations with fellow experts.
We look forward to seeing you in Geneva.
Venue
The Congress will take place at the Palexpo in Geneva, Switzerland
Organisation
ESMO Head Office
Via Ginevra 4
6900 Lugano
Switzerland
immuno@esmo.org
Press & News
The QuIP Study Attempts to Harmonise the Use of TMB Panels
BL-8040, Pembrolizumab and Chemotherapy Deliver Promising Disease Control in Patients with Metastatic Pancreatic Adenocarcinoma
Sitravatinib Plus Tislelizumab Show Promise in Platinum-Resistant Advanced Ovarian Cancer
Pembrolizumab May Be Considered as a First-Line Treatment Option in Non-Squamous NSCLC Even in the Presence of KRAS Mutations
Programme
Take a look at the Programme of the ESMO Immuno-Oncology Congress 2019!
